Physician profile
Jong Chul Park
NPI 1336307925
$20,432.77
in general payments reported to CMS, 2019-2025
12 companies · $291 in 2025
The $291 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,351 · 2020: $2,721 · 2021: $1,515 · 2022: $5,115 · 2023: $1,677 · 2024: $7,763 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,100 · Food and Beverage: $1,255 · Consulting Fee: $350 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,100.00 |
| Food and Beverage | $1,255.32 |
| Consulting Fee | $350.00 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coherus Oncology, INC. | $8,415.27 | 2022-2025 | Loqtorzi |
| Merck Sharp & Dohme LLC | $5,326.95 | 2019-2025 | Keytruda |
| Dr.Reddy'S Laboratories,INC. | $3,350.00 | 2024 | |
| Merck Kgaa | $2,415.00 | 2022 | |
| Galvanize Therapeutics, INC | $325.81 | 2023-2024 | Aliya System |
| Emd Serono, INC. | $221.00 | 2020 | |
| Caris Mpi, INC. | $110.63 | 2025 | Mi Cancer Seek |
| Regeneron Healthcare Solutions, INC. | $89.65 | 2025 | Libtayo |
| Tempus Ai, INC | $86.33 | 2024 | Xt Cdx |
| E.R. Squibb & Sons, L.L.C. | $50.00 | 2019 | |
| Abbott Laboratories | $27.63 | 2024 | Perclose Prostyle |
| Sanofi-Aventis U.S. LLC | $14.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jong Chul Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.